ArticleBMC urology2026
Risk factors for recurrence following robot-assisted laparoscopic partial nephrectomy (RAPN): a single-center retrospective study.
Article in BMC urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe recurrence rate after robot-assisted laparoscopic partial nephrectomy (RAPN) for renal cell carcinoma varies, and few established risk factors have been identified. We investigated recurrence rate and its risk factors following RAPN.
methodsAmong 221 patients who underwent RAPN at our institution from 2016 to 2024, we analyzed 205 patients diagnosed with renal cell carcinoma (excluding benign diseases). We retrospectively examined recurrence rates and risk factors.
resultsPostoperative recurrence was observed in 11 cases: 3 local recurrences and 8 non-local recurrences. The postoperative recurrence rate was 5.3%. The overall median follow-up duration for the full cohort was 63.5 months and the median time to postoperative recurrence was 15 months. Regarding perioperative findings, sex, lateral perirenal fat thickness, dorsal perirenal fat thickness, tumor size, operative time, warm ischemia time, pathological tumor (pT) stage ≥ 3a, and Fuhrman grade ≥ 3 were associated with postoperative recurrence status. A Cox regression analysis for recurrence-free survival was performed on factors associated with postoperative recurrence in the univariate analysis, and hazard ratios (HRs) were calculated. In particular, it was indicated that pT stage ≥ 3a (HR: 8.2, 95% confidence interval (CI): 2.0-33.8; p < 0.01) and Fuhrman grade ≥ 3 (HR: 9.2, 95% CI: 2.5-33.8; p < 0.01) might be associated with recurrence. However, postoperative recurrence occurred in only one of the seven cases with positive surgical margins, suggesting that no significant association was detected between positive surgical margins and recurrence in this cohort. Thirty-seven (18%) patients had either pT stage ≥ 3a or Fuhrman grade ≥ 3 (high-risk group). Compared with the 169 patients in the low-risk group (i.e., neither pT stage ≥ 3a nor Fuhrman grade ≥ 3), RFS was significantly shorter in patients meeting either criterion (HR: 15.6; 95% CI: 4.1-59.9; p < 0.01).
conclusionPositive surgical margin was not significantly associated with recurrence after RAPN for renal cell carcinoma, whereas pT stage ≥ 3a and Fuhrman grade ≥ 3 may be associated with recurrence. These findings should be interpreted with caution due to the limited number of events and require validation in larger studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.